作者: 彈藥 時(shí)間: 2025-3-21 22:00 作者: 磨坊 時(shí)間: 2025-3-22 01:19 作者: GNAW 時(shí)間: 2025-3-22 07:42
Constipation: Pathophysiology and Current Therapeutic Approaches,tantial healthcare utilization. In addition to infrequent bowel movements, the definition of constipation includes excessive straining, a sense of incomplete evacuation, failed or lengthy attempts to defecate, use of digital manoeuvres for evacuation of stool, abdominal bloating, and hard consistenc作者: 小淡水魚 時(shí)間: 2025-3-22 11:54 作者: 熒光 時(shí)間: 2025-3-22 16:33 作者: 熒光 時(shí)間: 2025-3-22 18:39 作者: 廣大 時(shí)間: 2025-3-23 00:15
Sex-Related Differences in GI Disorders,e a diagnosis than their male counterparts. However, the mechanism by which females exhibit an increased vulnerability for development of these pathophysiologies remains largely unknown, and therapeutic treatments are limited. The current chapter focuses on clinical research outlining our current kn作者: Malcontent 時(shí)間: 2025-3-23 05:09 作者: 谷類 時(shí)間: 2025-3-23 07:15
Irritable Bowel Syndrome and Stress-Related Psychiatric Co-morbidities: Focus on Early Life Stress,ominal pain and altered bowel movements. Stress-related disorders including anxiety and depression often precede the development of irritable bowel syndrome and vice versa. Stressor exposure during early life has the potential to increase an individual’s susceptibility to both irritable bowel syndro作者: AXIOM 時(shí)間: 2025-3-23 13:30
Neuroimmune Modulation of Gut Function,ls, which form a functional entity called the “neuroimmune synapse.” There are several mechanisms that further facilitate neuroimmune interactions including the anatomic proximity between immune cells and nerves, the expression of receptors for neurotransmitters on immune cells and for immune mediat作者: 擁擠前 時(shí)間: 2025-3-23 15:46 作者: AXIOM 時(shí)間: 2025-3-23 18:42 作者: 情感脆弱 時(shí)間: 2025-3-24 01:01 作者: PANIC 時(shí)間: 2025-3-24 05:02
Insights into the Role of Opioid Receptors in the GI Tract: Experimental Evidence and Therapeutic Rl dysfunction. Opioid drugs interact with three classes of opioid receptors: mu opioid receptors (MORs), delta opioid receptors (DOR), and kappa opioid receptors (KORs), but opioid drugs mostly target the MORs. Upon stimulation, opioid receptors couple to inhibitory Gi/Go proteins that activate or i作者: 意外的成功 時(shí)間: 2025-3-24 08:43 作者: Grating 時(shí)間: 2025-3-24 12:29
Centrally Targeted Pharmacotherapy for Chronic Abdominal Pain: Understanding and Management,erience within a biopsychosocial context are central in order to select treatment that has a chance for symptom reduction. With current knowledge of brain–gut interactions, chronic abdominal pain, which mostly appears in functional gastrointestinal disorders, to a large extent involves pain mechanis作者: Commentary 時(shí)間: 2025-3-24 17:14
The Role of the Gastrointestinal Microbiota in Visceral Pain,作者: Ophthalmoscope 時(shí)間: 2025-3-24 21:03 作者: 兇兆 時(shí)間: 2025-3-25 00:12
Constipation: Pathophysiology and Current Therapeutic Approaches,ges such as encouraging adequate fluid and fibre intake, regular exercise, and dietary modification. Laxatives are the mainstay of pharmacologic treatment for potential long-term therapy in patients who do not respond to lifestyle or dietary modification. After a failed empiric trial of laxatives, d作者: LARK 時(shí)間: 2025-3-25 04:53 作者: 音樂會(huì) 時(shí)間: 2025-3-25 09:37
Abnormal Barrier Function in Gastrointestinal Disorders,f structural gut alterations, at least in certain subsets, mainly in functional dyspepsia (FD) and irritable bowel syndrome (IBS). These alterations are associated with increased permeability, which seems to reflect mucosal inflammation and neural activation. The participation of each anatomical and作者: 證實(shí) 時(shí)間: 2025-3-25 12:37
Irritable Bowel Syndrome and Stress-Related Psychiatric Co-morbidities: Focus on Early Life Stress,axis is also seen in psychiatric disease. Here we review the co-morbidity of irritable bowel syndrome and psychiatric disease with their common origin in mind in relation to the impact of early life stress on the developing brain-gut-microbiota axis. We also discuss the therapeutic potential of targ作者: 苦笑 時(shí)間: 2025-3-25 19:35
Neuroimmune Modulation of Gut Function,croenvironment. In this context, the types of neurotransmitters released by activated neurons or immune cells can exert pro- or anti-inflammatory effects. Dysregulation of the enteric nervous system control of gastrointestinal functions, such as epithelial permeability and secretion as well as smoot作者: 鎮(zhèn)痛劑 時(shí)間: 2025-3-25 21:34 作者: 水土 時(shí)間: 2025-3-26 01:32 作者: 銼屑 時(shí)間: 2025-3-26 04:52 作者: 實(shí)施生效 時(shí)間: 2025-3-26 09:25
Ghrelin and Motilin Control Systems in GI Physiology and Therapeutics,r compounds that modulate the constitutive activity of the ghrelin receptor. Reduction of nausea may be the mechanism through which gastroparesis symptoms are reduced. Intriguingly, a potential ability of motilin to influence nausea is also becoming apparent. Ghrelin interacts with digestive functio作者: OTHER 時(shí)間: 2025-3-26 15:28
Inverted T Pattern Breast Reductionlent disorders, with the most common including esophageal and swallowing disorders, gastric and peptic ulcer disease, gastroparesis or delayed gastric emptying, irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD). Many GI disorders are difficult to diagnose and their symptoms are no作者: Macronutrients 時(shí)間: 2025-3-26 17:58
Alan Crivellaro,Fritz Hans Schweingruberges such as encouraging adequate fluid and fibre intake, regular exercise, and dietary modification. Laxatives are the mainstay of pharmacologic treatment for potential long-term therapy in patients who do not respond to lifestyle or dietary modification. After a failed empiric trial of laxatives, d作者: fatty-acids 時(shí)間: 2025-3-26 23:57 作者: 寬大 時(shí)間: 2025-3-27 03:36 作者: 詞匯記憶方法 時(shí)間: 2025-3-27 05:24
The shape and composition of otoconiaaxis is also seen in psychiatric disease. Here we review the co-morbidity of irritable bowel syndrome and psychiatric disease with their common origin in mind in relation to the impact of early life stress on the developing brain-gut-microbiota axis. We also discuss the therapeutic potential of targ作者: 砍伐 時(shí)間: 2025-3-27 12:13
https://doi.org/10.1007/978-3-030-94833-7croenvironment. In this context, the types of neurotransmitters released by activated neurons or immune cells can exert pro- or anti-inflammatory effects. Dysregulation of the enteric nervous system control of gastrointestinal functions, such as epithelial permeability and secretion as well as smoot作者: Strength 時(shí)間: 2025-3-27 15:00
https://doi.org/10.1007/978-94-017-8619-5lidity of each model, and the limitations of each model, including data interpretation, are highlighted. This chapter does not evaluate models that rely on surgical or other non-pharmacological interventions for treatment.作者: GEST 時(shí)間: 2025-3-27 20:55 作者: exophthalmos 時(shí)間: 2025-3-28 01:29 作者: Aggrandize 時(shí)間: 2025-3-28 06:03
https://doi.org/10.1007/978-94-011-7330-8r compounds that modulate the constitutive activity of the ghrelin receptor. Reduction of nausea may be the mechanism through which gastroparesis symptoms are reduced. Intriguingly, a potential ability of motilin to influence nausea is also becoming apparent. Ghrelin interacts with digestive functio作者: 道學(xué)氣 時(shí)間: 2025-3-28 08:35 作者: Creditee 時(shí)間: 2025-3-28 11:18 作者: 敲竹杠 時(shí)間: 2025-3-28 16:13 作者: Isometric 時(shí)間: 2025-3-28 19:43
https://doi.org/10.1007/978-3-319-17864-6. This chapter covers the pathophysiology and current treatment approaches to disorders of the upper gastrointestinal tract, focusing on classic disorders of the stomach, particularly gastroparesis and functional dyspepsia.作者: cylinder 時(shí)間: 2025-3-28 23:29
Pneumatosis cystoides intestinalis manifestation of symptoms observed within the patient population. Although much progress has been made, additional longitudinal studies in both clinical and preclinical research are necessary to identify more specific mechanisms underlying sex-related differences in FGIDs as well as targets for improved therapeutic approaches.作者: Anal-Canal 時(shí)間: 2025-3-29 03:20 作者: Hormones 時(shí)間: 2025-3-29 08:18
Upper GI Disorders: Pathophysiology and Current Therapeutic Approaches,. This chapter covers the pathophysiology and current treatment approaches to disorders of the upper gastrointestinal tract, focusing on classic disorders of the stomach, particularly gastroparesis and functional dyspepsia.作者: 類似思想 時(shí)間: 2025-3-29 14:02 作者: 地殼 時(shí)間: 2025-3-29 16:28
Centrally Targeted Pharmacotherapy for Chronic Abdominal Pain: Understanding and Management, refers to when there is insufficient effect of one drug alone or side effects limiting dosage, and when combined in lower doses, certain drugs give rise to augmentation effects. This chapter outlines basic mechanisms of importance for the understanding of chronic abdominal pain and the pharmacologic treatment options.作者: 人類的發(fā)源 時(shí)間: 2025-3-29 22:02
Serotonergic Mechanisms Regulating the GI Tract: Experimental Evidence and Therapeutic Relevance,rine actions. This chapter provides the most current knowledge of the critical autocrine and paracrine roles of 5-HT in intestinal motility and inflammation as well as its function as a hormone in osteocyte homeostasis. Therapeutic applications in each of these areas are also discussed.作者: 描繪 時(shí)間: 2025-3-30 01:39
Lijuan Shi,Zhipeng Wang,Senrong Qi The latter starts after 3–6 h and lasts several days, making it a more interesting target for treatment. Insight into the triggers and immune cells involved is of great importance for the development of new therapeutic strategies. In this chapter, the pathogenesis and the current therapeutic approaches to treat postoperative ileus are discussed.作者: AND 時(shí)間: 2025-3-30 05:18
Modification of the Xylem Within a Plant,unmet need for effective treatments, particularly for the pain component of IBS, although the introduction of drugs directed at secretion, motility, and a nonabsorbable antibiotic provides an option for the bowel dysfunction in IBS.作者: Inoperable 時(shí)間: 2025-3-30 08:41
Postoperative Ileus: Pathophysiology, Current Therapeutic Approaches, The latter starts after 3–6 h and lasts several days, making it a more interesting target for treatment. Insight into the triggers and immune cells involved is of great importance for the development of new therapeutic strategies. In this chapter, the pathogenesis and the current therapeutic approaches to treat postoperative ileus are discussed.作者: 我不死扛 時(shí)間: 2025-3-30 14:56
Irritable Bowel Syndrome: Pathophysiology and Current Therapeutic Approaches,unmet need for effective treatments, particularly for the pain component of IBS, although the introduction of drugs directed at secretion, motility, and a nonabsorbable antibiotic provides an option for the bowel dysfunction in IBS.作者: 我正派 時(shí)間: 2025-3-30 17:41 作者: 意外 時(shí)間: 2025-3-30 22:27 作者: 無彈性 時(shí)間: 2025-3-31 01:31 作者: Medley 時(shí)間: 2025-3-31 09:04
https://doi.org/10.1007/978-3-319-56360-2Gastrointestinal disorders; Gut microbiome; Gastrointestinal cancer; Enteric physiology; Receptor pharma
